Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes (Pediatric) Clinical Trials

A listing of Diabetes (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (33) clinical trials

The purpose of this research study is to investigate whether the trial product is effective and safe in reducing/managing weight in children. Winthrop-University Hospital Clinical Trials Center is seeking study participants (ages 7-11 years old), who have not started puberty to take part in this clinical research study because he/she ...

Phase

Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for participants (ages 10-17 years old), who have been diagnosed with type 2 diabetes. The purpose of this research study is to test the safety and effectiveness of an oral investigational drug to lower blood sugar in Pediatric ...

Phase

This study will evaluate the efficacy and safety of alogliptin 25 mg once daily (QD) compared to placebo when administered as monotherapy, or when added onto a background of metformin alone, insulin alone, or a combination of metformin and insulin in pediatric participants 10 to 17 years of age with ...

Phase

Be part of a new approach to diabetes care! AMCR Institute is currently recruiting for clinical trials to evaluate medical devices and investigational medications for pediatric and adult individuals with Type 1, Type 2 Diabetes and obesity. AMCR Institute's team is committed to providing superior service to our volunteers and ...

Phase N/A

Researchers at the University of Kentucky are inviting you to participate in a study about the effects of myostatin, a molecule secreted by muscle, on diabetic bone. You are being invited to take part in this research study because you are 18 to 45 years old, have Type 1 diabetes ...

Phase N/A

The purpose of this study is to assess the safety and tolerability of different doses of AG019 administered alone or in combination with teplizumab in participants who recently developed Type 1 Diabetes Mellitus (T1D).  

Phase

Patients with type 2 diabetes have higher levels of blood glucose (sugar) than patients who do not have this disease. The high level of sugar in the blood can lead to serious short-term and long-term medical problems. The main goal of treating diabetic patients is to lower blood glucose to ...

Phase

The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).  

Phase

The purpose of this study is to determine whether teplizumab slows the loss of β cells and preserves β cell function in children and adolescent 8-17 years old who have been diagnosed with T1D in the previous 6 weeks.. Subjects will receive two courses of either teplizumab or placebo treatment ...

Phase

TYPE 2 DIABETES IN CHILDREN IS A CHRONIC DISEASE THAT AFFECTS THE WAY YOUR CHILD'S BODY PROCESSES SUGAR (GLUCOSE).  

Phase